ad image

IssueQ32022

1 / 2
Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers
mRNA Manufacture

Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers

Tonia Becker

Nice Insight

PAO-10-022-CL-03Oct 25, 2022
Formulating Flexibility with ActiMask® Taste Masking
Taste Masking Formulations

Formulating Flexibility with ActiMask® Taste Masking

SPI Pharma

PAO-10-022-CL-05Oct 25, 2022
Risk-Based Optimization of Viral Vector Processes Adds Real Value
Viral Vectors

Risk-Based Optimization of Viral Vector Processes Adds Real Value

Elie Hanania, Ph.D.; Tatiana Mello, M.S.

Avid Bioservices

PAO-09-022-CL-05Oct 25, 2022
Overcoming Bottlenecks in mRNA Manufacturing
mRNA Manufacturing

Overcoming Bottlenecks in mRNA Manufacturing

Pierre Catignol; Huisub Lim

Samsung Biologics

PAO-10-022-CL-04Oct 24, 2022
Antibiotic Resistance: Advances in Understanding and Drug Development
Antibiotic Resistance

Antibiotic Resistance: Advances in Understanding and Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-10-022-NI-07Oct 11, 2022
Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand
Column: New Drug Watch

Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-10-022-NI-06Oct 11, 2022
State of the Cell and Gene Therapy Market
Cell and Gene Therapy

State of the Cell and Gene Therapy Market

James Grote

Nice Insight

PAO-10-022-NI-01Oct 11, 2022
Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties
mRNA

Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-10-022-NI-02Oct 11, 2022
Examining the Potential of Precision/Personalized Medicine
Precision Medicine

Examining the Potential of Precision/Personalized Medicine

David Alvaro, Ph.D.

Pharma's Almanac

PAO-10-022-NI-03Oct 11, 2022
Reimagining the Pharmaceutical Supply Chain
Column: Supply Chain

Reimagining the Pharmaceutical Supply Chain

Danielle Alvarez

Pharma's Almanac

PAO-10-022-NI-04Oct 11, 2022
Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More
Big Data

Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

PAO-10-022-NI-05Oct 11, 2022
What key indicators do you look at to predict the future of this industry?
Future of the Industry

What key indicators do you look at to predict the future of this industry?

Pharma's Almanac

PAO-10-022--RT-02Oct 11, 2022
What is your plan to build a more sustainable business practice in the coming years?
Sustainability

What is your plan to build a more sustainable business practice in the coming years?

Pharma's Almanac

PAO-10-022--RT-01Oct 11, 2022
Overcoming Limitations with Transient Protein Expression to Accelerate Development
Transient Expression

Overcoming Limitations with Transient Protein Expression to Accelerate Development

Cenk Sumen, Ph.D.

MaxCyte

PAO-10-022-CL-02Oct 11, 2022
How All Clinical Trial Stakeholders Can Collaborate as One Study Team
Clinical Workflow Integration

How All Clinical Trial Stakeholders Can Collaborate as One Study Team

OneStudyTeam

PAO-10-022-CL-01Oct 10, 2022
Raman Spectroscopy as a PAT Tool Advancing Biopharma Manufacturing
Real-Time Monitoring

Raman Spectroscopy as a PAT Tool Advancing Biopharma Manufacturing

Stacy Shollenberger

MilliporeSigma

PAO-09-022-CL-08Sep 30, 2022
Beyond Drug Sales: Adding Value with Digital Health
Digital Health Solutions

Beyond Drug Sales: Adding Value with Digital Health

Gérard Klop; Marcos Gallego Llorente, Ph.D.

PAO-08-022-CL-05Sep 28, 2022
Leveraging Experience to Reduce Timelines for IND-Enabling Activities
Speed to Clinic

Leveraging Experience to Reduce Timelines for IND-Enabling Activities

Muctarr Sesay, Ph.D.; Andrew Majdoch, M.Sc.

GBI

PAO-09-022-CL-04Sep 19, 2022
Supporting Biodefense Countermeasures with Strong Capabilities and Expertise
Biodefense

Supporting Biodefense Countermeasures with Strong Capabilities and Expertise

Brian O’Mara

Scorpius BioManufacturing

PAO-09-022-CL-03Sep 19, 2022
Asymchem: Leading with Technology
CDMO

Asymchem: Leading with Technology

Asymchem

PAO-09-022-CL-01Sep 13, 2022
1 / 2